Brief: Amicus Therapeutics Total Revenue Was $103.5 Million In Q3 2023, Increase Of 27%

Amicus Therapeutics

08/11/2023 12:28

Nov 8 (Reuters) - Amicus Therapeutics Inc  FOLD.O :
    * TOTAL REVENUES WERE $103.5 MILLION IN Q3 2023, A
YEAR-OVER-YEAR
INCREASE OF 27%
    * ON-TRACK TO ACHIEVE NON-GAAP PROFITABILITY IN Q4 OF 2023

Source text for Eikon:  ID:nGNX2vRfwz 
Further company coverage:  FOLD.O 

 ((Reuters.Briefs@thomsonreuters.com;))